Stonehage Fleming (UK)’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,894	Closed	-$46K	–	261
2014 Q1	$46K	Sell	1,894 -931	-33%	-$22.6K	0.02%	260
2013 Q4	$71K	Buy	+2,825	New	+$71K	0.03%	190